(Q43100561)

13 November 2017

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients (English)

1 reference

13 November 2017

2

1 reference

13 November 2017

Ramasamy Kesavan

1

1 reference

PubMed ID

20390258

13 November 2017

Chandrasekaran Adithan

series ordinal

3

1 reference

13 November 2017

1 July 2010

1 reference

European Journal of Clinical Pharmacology

13 November 2017

1 reference

13 November 2017

66

1 reference

13 November 2017

7

1 reference

13 November 2017

689-696

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-010-0817-2

13 November 2017

0 references

cites work

Severe intoxication after phenytoin infusion: a preventable pharmacogenetic adverse reaction.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-010-0817-2

DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-010-0817-2

Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.

21 January 2018

1 reference

12 December 2020

Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite

1 reference

12 December 2020

Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

1 reference

12 December 2020

Influence of the CYP2C9 AND CYP2C19 polymorphisms on phenytoin hydroxylation in healthy individuals from south India.

1 reference

12 December 2020

Acenocoumarol and phenytoin toxicity in the presence of CYP2C9 mutation

1 reference

12 December 2020

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

1 reference

12 December 2020

The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels

1 reference

12 December 2020

Allele frequency of CYP2C9 gene polymorphisms in Iran

1 reference

12 December 2020

Effect of CYP2C19 genetic polymorphism on pharmacokinetics of phenytoin and phenobarbital in Japanese epileptic patients using Non-linear Mixed Effects Model approach.

1 reference

12 December 2020

Allele and genotype frequency of CYP2C19 in a Tamilian population

1 reference

12 December 2020

A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin.

1 reference

12 December 2020

Effect of CYP2C polymorphisms on the pharmacokinetics of phenytoin in Japanese patients with epilepsy

1 reference

12 December 2020

Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations

1 reference

12 December 2020

Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin

1 reference

12 December 2020

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9

1 reference

12 December 2020

The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism

1 reference

12 December 2020

Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy

1 reference

12 December 2020

Antiepileptic agents--primidone, phenobarbital, phenytoin, and carbamazepine by reversed-phase liquid chromatography.

1 reference

12 December 2020

Paradoxical Intoxication,:A Complication of Anticonvulsant Administration

1 reference

12 December 2020

The relationship between phenytoin pharmacokinetics and the CYP2C19 genotype in Japanese epileptic patients.

1 reference

12 December 2020

The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics

1 reference

12 December 2020

DNA sequencing with chain-terminating inhibitors

1 reference

12 December 2020

Genetic polymorphism of cytochrome P450 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions

1 reference

12 December 2020

Allele and genotype frequency of CYP2C9 in Tamilnadu population

1 reference

12 December 2020

Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin

1 reference

12 December 2020

CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates

1 reference

12 December 2020

Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.

1 reference

12 December 2020

CYP2C9, CYP2C19, and ABCB1 genotype and hospitalization for phenytoin toxicity

1 reference

12 December 2020

Allele and genotype frequencies of CYP2C9 in a Korean population

1 reference

12 December 2020

Phenytoin toxicity due to genetic polymorphism

1 reference

12 December 2020

Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin concentration with central nervous system intoxication

1 reference

12 December 2020

CYP2C9 allelic variants: ethnic distribution and functional significance

1 reference

12 December 2020

Allele frequency differences of cytochrome P450 polymorphisms in a sample of New Zealand Māori.

1 reference

12 December 2020

The pharmacogenetics of CYP2C9 and CYP2C19: ethnic variation and clinical significance

1 reference

12 December 2020

Severe phenytoin toxicity in a CYP2C9*3*3 homozygous mutant from India

1 reference

12 December 2020

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

1 reference

12 December 2020

Reconstructing Indian population history

1 reference

12 December 2020

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

1 reference

12 December 2020

10.1007/S00228-010-0817-2

Identifiers

DOI

1 reference

release_5yywvz5rpzexjnwfm67wpt7yzi

13 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5yywvz5rpzexjnwfm67wpt7yzi

24 November 2022

mapped directly with Wikidata item

PubMed ID

20390258

1 reference

PubMed ID

20390258